Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

September 30, 2013

Conditions
Neisseria Meningitidis
Interventions
BIOLOGICAL

MenBvac

Blood test

Trial Locations (1)

76270

Maison Du Département, Neufchâtel-en-Bray

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Direction Générale de la Santé, France

OTHER

collaborator

Institut Pasteur

INDUSTRY

lead

University Hospital, Rouen

OTHER

NCT01621945 - Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC) | Biotech Hunter | Biotech Hunter